Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from ProText Mobility ( (TXTM) ) is now available.
ProText Mobility, Inc., a former SEC-reporting company trading on OTC markets, is voluntarily resuming EDGAR filings and enhancing its digital disclosure infrastructure as it prepares for a potential uplisting to a major global exchange. The company reported on Nov. 19, 2025, that it maintains a $505 million debt-free balance sheet with no dilution or reverse split, has completed IFRS-audited 2022 and 2023 financials with 2024 filings in progress, and is leveraging FX tailwinds, seed-to-API monetization, and RWA tokenization to strengthen its balance sheet and EBITDA.
The update highlighted strategic support already received under the TruLeaf LOI, recognized as income under IFRS, which bolsters operational readiness and early-stage commercial development without cash outlay. ProText also announced the appointment of the Ambassador of Chad to its advisory board and continued insider share purchases, moves that reinforce its international positioning, governance, and management alignment with shareholders as it seeks greater transparency, regulatory readiness, and long-term value creation.
More about ProText Mobility
ProText Mobility, Inc. operates in the nutraceutical and pharmaceutical sectors, focusing on research, testing, and development of highly bioavailable, nanotechnology-based botanical formulations. Using proprietary live plant extraction technologies, the company aims to advance plant-based therapeutics for global wellness and health applications, including converting seed inventory into active pharmaceutical ingredients at scale.
Current Market Cap: $58.51M
See more data about TXTM stock on TipRanks’ Stock Analysis page.